Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy

Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterised by significant clinical heterogeneity and as such reliable biomarkers are required to measure disease activity and assess treatment response. Recent advances in our understanding of disease pathogenesis and the discovery of no...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoo, Anthony, Frasca, Joseph, Schultz, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373155/
https://www.ncbi.nlm.nih.gov/pubmed/30805188
http://dx.doi.org/10.1186/s40364-019-0154-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373155/
https://www.ncbi.nlm.nih.gov/pubmed/30805188
http://dx.doi.org/10.1186/s40364-019-0154-2

Ejemplares similares